NCT05674552View on ClinicalTrials.gov

Exogenous Ketone Esters for Refractory Status Epileptics

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

July 1, 2025

Conditions
Status Epilepticus
Interventions
DRUG

Exogenous ketone ester

500 mg/kg over 5 min administered by nasogastric tube, followed after 1 hr by repeated hourly doses of 125 mg/kg for 8 hrs.

Trial Locations (1)

82524

RECRUITING

Department of Pediatrics at Sohag University Hospital, Sohag

All Listed Sponsors
lead

Sohag University

OTHER